Decreased EPO levels resulting from liver dysfunction may contribute to ineffective erythropoiesis, resulting in anisocytosis and increased RDW. In advanced liver disorders, such as cirrhosis, portal hypertension can develop due to increased resistance to blood flow within the liver. This evidence concerns the gene EPO and liver disorder.